Skip to main content
Clinical Trials/JPRN-UMIN000012829
JPRN-UMIN000012829
Completed
Phase 1

Clinical test for development of novel skin care method by augmentation of Staphylococcus epidermidis, an autologous skin microbiota - Clinical test for development of novel skin care method by augmentation of Staphylococcus epidermidis, an autologous skin microbiota

agasaki International University0 sites20 target enrollmentJanuary 12, 2014

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Improvement of skin moisture retention
Sponsor
agasaki International University
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The augmentation of S. epidermidis increased the lipid content of the skin and improved moisture retention. This treatment also improved any rough skin texture and maintained a low acidic condition on the skin surface. There were few undesirable effects caused by the augmentation of S. epidermidis as was demonstrated by measuring erythema and melanin levels.

Registry
who.int
Start Date
January 12, 2014
End Date
June 30, 2012
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
agasaki International University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients were excluded if they had any dermatological disease.

Outcomes

Primary Outcomes

Not specified

Similar Trials